Seroprevalence of SARS-CoV-2 Antibodies in Symptomatic Individuals Is Higher than in Persons Who Are at Increased Risk Exposure: The Results of the Single-Center, Prospective, Cross-Sectional Study

The present study aimed to assess antibody seropositivity prevalence among symptomatic individuals and individuals with a high risk of occupational exposure to SARS-CoV-2. Participants from Chelyabinsk (Russian Federation) who were at an increased risk of exposure to SARS-CoV-2 (high-risk group, n =...

Descripción completa

Detalles Bibliográficos
Autores principales: Zurochka, Alexandr, Dobrinina, Maria, Zurochka, Vladimir, Hu, Desheng, Solovyev, Alexandr, Ryabova, Liana, Kritsky, Igor, Ibragimov, Roman, Sarapultsev, Alexey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229032/
https://www.ncbi.nlm.nih.gov/pubmed/34207919
http://dx.doi.org/10.3390/vaccines9060627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229032/
https://www.ncbi.nlm.nih.gov/pubmed/34207919
http://dx.doi.org/10.3390/vaccines9060627

Ejemplares similares